SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle's stock is under pressure following earnings results that sparked concerns about heavy AI-related spending and its impact on future profitability; the community is closely watching key support levels. Some believe this is an overreaction and a buying opportunity, while others fear the company's debt and cash flow issues could continue to weigh on the stock. Chatter suggests a broader reassessment of AI-exposed companies is underway as investors digest the implications of Oracle's report.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending downwards as investors discuss customer losses and a recent analyst price cut, leading to concerns about its competitive position against larger platforms; the stock is nearing 52-week lows, sparking debates about potential takeover bids and whether it's a buying opportunity or a value trap given tax-loss selling pressures and potential Nasdaq 100 exclusion.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors discuss its potential in treating cancers, particularly after positive data in prostate cancer trials, while also citing undervaluation. The community is actively discussing the possibility of a short squeeze given the high short interest. Some also speculate about potential partnerships and acquisitions in the near future! LOAD!

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

GEMI is trending due to its derivatives arm, Gemini Titan, securing a CFTC license to launch regulated prediction markets in the U.S., a move celebrated by CEO Tyler Winklevoss. Community chatter highlights the potential for a short squeeze and increased valuation, with some drawing comparisons to prediction market competitors. The license is viewed as a significant catalyst, potentially unlocking substantial growth amid the broader crypto adoption boom.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to its upcoming Autonomy and AI Day, with community members anticipating announcements around self-driving capabilities and in-house chip technology. Discussions also involve Rivian's potential to compete with Tesla and other EV makers, alongside mentions of production improvements and expansion plans. Overall, the community buzz reflects excitement and high expectations for Rivian's technological advancements in the EV sector.

Black Titan Corp. was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. It intends to explore and identify viable business opportunities. The company was founded on July 11, 2024 and is headquartered in Petaling Jaya, Malaysia.

Black Titan Corp.

Black Titan Corp. is trending as community members discuss its recent surge following news of its strategic entry into digital assets. Traders are actively debating holding strategies amidst volatility, with some pointing to dilution concerns and potential short squeeze opportunities. The stock's low float and potential for further news related to its digital asset framework are also fueling interest.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending as traders anticipate news from an upcoming conference and potential operational updates, focusing on the company's shift towards AI infrastructure and efficient energy use. Community members are actively discussing price targets and potential short squeezes, citing the stock's low float and past volatility. This buzz comes after the company resolved a legal battle with its former CEO, which is now seen as a positive catalyst for its re-emergence.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending as investors anticipate earnings, especially in light of potential AI chip deals with major tech companies like Microsoft. Community discussions revolve around whether Broadcom can deliver strong guidance and justify its valuation amidst broader concerns of an AI spending slowdown. Bullish sentiment is fueled by expectations of significant AI revenue growth and the company's history of exceeding estimates.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood ($HOOD) is trending amid discussions about its recent price action and correlation with crypto markets like Bitcoin, with some traders pointing to potential overbought conditions and profit-taking. Community members are also weighing in on the stock's long-term potential, the impact of news, and the potential implications of regulatory actions and expansion into new markets. The stock's performance is being actively compared to competitors like SoFi.

AXIL Brands, Inc. engages in the manufacture, market, sale and distribution of hearing and audio enhancement, and protection products. It operates through the Hearing Enhancement and Protection, and Hair Care and Skin Care segments. The Hearing Enhancement and Protection segment includes ear buds, earmuffs, ear plugs, outdoor speakers, and ear care items. The Hair Care and Skin Care segment focuses on expanding its business-to-business salon sales through its network of domestic and international distributors. The company was founded on May 21, 2015 and is headquartered in Beverly Hills, CA.

AXIL Brands Inc.

AXIL Brands is trending as traders discuss its distribution agreement with Walmart, which led to significant pre-market gains and a surge in volume. Community chatter revolves around whether the stock can sustain its momentum and break past resistance levels, with some anticipating a potential short squeeze, while others express skepticism and caution against chasing the rally. Discussions also involve comparisons to other companies in the hearing enhancement industry and speculation about institutional interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Protagenic Therapeutics, Inc. (PTIX) jumped 244% on Monday morning after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.pressviewer.com/profiles/investor/NewsPrint.asp?v=6&amp;b=2612&amp;ID=145678&amp;m=rl&amp;g=1834">announced</a> its merger with private pharmaceutical firm Phytanix Bio Inc.Protagenic said the two companies have entered into a definitive share exchange agreement, under which they will combine in an all-stock transaction.The combined entity will be called Phytanix, Inc., and will bring together the two companies’ pipelines focused on stress-related and central nervous system (CNS) disorders. While Protagenic makes peptides for stress-related disorders, Phytanix Bio specializes in developing medicines manufactured from cannabinoids and "cannabinoid-like" molecules.The combined entity will have five preclinical assets and one clinical-stage asset, Protagenic added.Protagenic executive chairman Garo H. Armen noted that the combination aligns two pipelines with complementary assets and expertise to develop drugs in neuropsychiatry, CNS, and other disorders.Protagenic said that post-combination, pre-financing ownership will be approximately 35% for the company's pre-combination stockholders and approximately 65% for Phytanix Bio stockholders on a fully diluted basis.Protagenic had announced a 1-for-14 reverse stock split of its issued and outstanding common stock earlier this month to bring the company into compliance with the minimum bid price requirement for continued listing on Nasdaq.On Stocktwits, retail sentiment around Protagenic jumped from ‘neutral’ to ‘extremely bullish’ over the past 24 hours while message volume jumped from ‘high’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:628/65;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_19_at_10_28_13_AM_png_a07fae3fc6.webp" alt="PTIX's Sentiment Meter and Message Volume as of 10:30 a.m. ET on May 19, 2025 | Source: Stocktwits" width="628" height="65"><figcaption>PTIX's Sentiment Meter and Message Volume as of 10:30 a.m. ET on May 19, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user believes the stock could rally further toward $15.<stembedurl>https://stocktwits.com/cjstocksup/message/615100995</stembedurl><a href="https://stocktwits.com/symbol/PTIX">PTIX stock</a> gained over 43% this year but is down by about 48% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/netflix-stock-edges-lower-after-jp-morgan-downgrade-despite-higher-price-target/ch0cubqRb82">Netflix Stock Edges Lower After JPMorgan Downgrade Despite Higher Price Target</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Protagenic Therapeutics Merges With Phytanix Bio In All-Stock Deal: Retail Turns Extremely Bullish

The new entity will be called Phytanix, Inc., and it will combine the two companies’ pipelines focused on stress-related and CNS disorders.

Equity

Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.

Protagenic Therapeutics Inc

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

PTIX
Protagenic Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest PTIX News

PTIXProtagenic Therapeutics Inc